Navigation Links
Vasogen Announces Third Quarter 2007 Results
Date:10/9/2007

32,840 $ 41,770

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Liabilities and Shareholders' Equity

Current liabilities:

Accounts payable $ 537 $ 3,369

Accrued liabilities 3,267 5,067

Senior convertible notes payable - 8,754

-----------------------------------------------------------------------

3,804 17,190

Shareholders' equity:

Share capital:

Authorized:

Unlimited common shares, without par value

Issued and outstanding:

22,391,387 common shares

(November 30, 2006 - 15,665,134) 365,670 344,217

Stock-based compensation 10,958 10,713

Equity component of senior convertible

notes payable - 1,639

Warrants 16,725 11,390

Contributed surplus 11,408 7,995

Deficit (375,725) (351,374)

-----------------------------------------------------------------------

29,036 24,580

Commitments and contingencies

-------------------------------------------------------------------------

$ 32,840 $ 41,770

-------------------------------------------------------------------------

-------------------------------------------------------------------------

VASOGEN INC.

(A DEVELOPMENT STAGE COMPANY)

Interim Consolidated Statements of Operations, Def
'/>"/>

SOURCE Vasogen Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... GlassesOff (OTCBB: GLSO), a visual neuroscience technology company ... system, announced today a partnership with eight-time All-Star, ... to develop a new mobile app designed for professional and ... performance. Vision is the inception of every move ... or blocking a pass. The critical impact vision speed has ...
(Date:8/26/2015)... ... August 26, 2015 , ... MediVet Biologics, a leader ... laboratory is to open in Manhattan, Kansas in early October, 2015. The location ... of research and development through collaboration with researchers from Kansas State University’s College ...
(Date:8/26/2015)... Aug. 26, 2015  Platform therapeutic company Symic ... received a $1.5M Phase II SBIR grant from ... develop its therapeutic agent to reduce arteriovenous fistula ... end stage renal disease (ESRD) patients undergoing hemodialysis. ... of Diabetes and Digestive and Kidney Diseases (NIDDK), ...
(Date:8/26/2015)... Florida , August 26, 2015 ... the biggest factors fueling the optimism in biotech,s ... M&A,s, collaborations and life sciences advancements.  Active biotechnology ... are Pressure BioSciences, Inc. (OTCQB: PBIO), Sequenom, Inc. ... SRPT ), Raptor Pharmaceutical Corp. (NASDAQ: ...
Breaking Biology Technology:Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 3MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 2New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 5New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 6New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 7
... Italy, November 10 Health-Robotics today,announced that ... Automation since,1971, has selected Health Robotics, CytoCare(TM) ... by TOSHO,s engineering and management,teams, and by ... process included multiple visits to Health Robotics, ...
... Delivery Technology and own Pipeline ... ... 10 Critical,Pharmaceuticals, the speciality pharmaceuticals company, today announced,that it ... on the company,s success in developing its unique,CriticalMix delivery technology ...
... and research group Plasma & Materials Processing (PMP) of ... awarded the Leverhulme Technology Transfer Award 2008. They receive ... for the research group) for their successful transfer of ... Hoex,s Ph.D. research was rewarded with the SolarWorld Junior ...
Cached Biology Technology:Health Robotics Announces Strategic Partnership in Japan for its CytoCare(TM) Robot with TOSHO Inc. 2Health Robotics Announces Strategic Partnership in Japan for its CytoCare(TM) Robot with TOSHO Inc. 3Health Robotics Announces Strategic Partnership in Japan for its CytoCare(TM) Robot with TOSHO Inc. 4Critical Pharmaceuticals Raise GBP650K 2Critical Pharmaceuticals Raise GBP650K 3TU/e awarded for knowledge transfer to solar energy industry 2
(Date:8/5/2015)... 2015 Transparency Market Research has ... - Global Industry Analysis, Size, Share, Growth, Trends and ... recognition is forecast to reach US$ 2,671.8 Mn by ... surveillance systems by civil and government agencies. This is ... terrorist activities across the globe that would elevate the ...
(Date:8/3/2015)... , Aug. 3, 2015 Synaptics, Inc. (Nasdaq: ... solutions, today announced that members of the executive management ... Pacific Crest Global Technology Leadership Forum on Tuesday, August ... will be held at the Sonnenalp Resort in ... presentation may include forward-looking information. An audio webcast of ...
(Date:7/31/2015)... , Chine, 31 juillet 2015 ... www.icg-10.org ) sera organisée par le BGI ... Shenzhen en Chine. ... Depuis son inauguration en 2006, l,ICG est devenue ... dans le domaine des « omiques » et c,est aussi ...
Breaking Biology News(10 mins):Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3
... 28, 2012 In 2012 Wiley-Blackwell, the Scientific, Technical, ... Sons, Inc., will begin publishing 44 titles new to ... journals published in collaboration with societies or other organizations. ... over the course of 2012 include Advanced Healthcare ...
... The bacterium Mycoplasma pneumoniae , which causes ... the most of limited resources. By measuring all the ... Biology Laboratory (EMBL) in Heidelberg, Germany, and collaborators, have ... a mechanic can fine-tune a car after it has ...
... SANTA CLARA, Calif., and SHENZHEN, China, Feb. ... and BGI today announced a collaborative effort to ... The methodologies will assist scientists pursuing disease and ... is to create a next-generation super exome, using ...
Cached Biology News:Wiley-Blackwell adds 44 titles to journal publishing program in 2012 2Making the most of what you have 2Agilent Technologies and BGI to collaborate on next-generation super array 2
... DNA Ligase catalyzes the formation of a ... termini in nicked duplex DNA molecules or ... a complementary strand at 45 - 65?. ... at much higher temperatures than conventional DNA ...
MAb to Mouse MHC Class I H-2Kd...
hnRNP U (H-94)...
Rabbit polyclonal antibody to Neuromedin U Receptor 1 (GPR66)...
Biology Products: